MULTIPLE CHOICE:

______ 1. What is the pharmaceutical component of the vaccine against Hepatitis B Virus?
a. IgG and IgM antibodies
b. mutated nucleus of virus
c. viral envelope proteins, hepatitis B surface antigen (HBsAg).
d. plasma membrane infection plasticity
* rationale: The vaccine use for the prevention of hepatitis b virus infection contains viral envelope proteins and
hepatitis B surface antigen (HBsAg).

______ 2. Which of the following is one of the mechanisms of Polio virus to evade the immune system?
a. react as if the body were actually being infected
b. capable of surviving the highly acidic conditions of the gastrointestinal tract
c. that interfere with viral replication
d. reduce the physical severity of outbreak-associated lesions
*rationale: It allows the virus to infect the host and spread throughout the body via the lymphatic system and it can
replicate very quickly that the virus overwhelms the host organs before an immune response can be mounted.
______ 3. What is the most dangerous adverse effect of Influenza Vaccines?
a. affected eye sight of the host
b. severe allergic reactions
c. fatal neurological conditions
d. vomiting and nausea
*rationale: This vaccines can cause the immune system to react as if the body were actually infected.
______ 4. What are the common antiviral that reduce reactivation rates Herpes Virus?
a. ribavirin
b. indinavir sulfate
c. lamivudine
d. acyclovir and valacyclovir
*rationale: Antiviral drugs that interfere with viral replication reduce the physical severity of outbreak-associated lesions
and lower the chance of transmission to others.
______ 5. What is the possible way to slow down or completely stop the infection of the given
parvovirus?
a. Slight mutations of binding sites
b. Modification of the core DNA
c. Eradication of virus to the host cell
d. Recombination of DNA in the nucleus
*rationale: Although transferrin receptors may be limited on cell surfaces the parvo viruses will find available

transferrin receptors and will use different pathways to gain entry to the cells plasma membrane.